ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 973

$600K Total Retail Price of All Prescriptions

Rank: 81 out of 973

375 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 375 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,528 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
FUROSEMIDE 435 412 1 6
LEVOTHYROXINE SODIUM 410 367 2 2
SIMVASTATIN 409 327 3 1
POTASSIUM CHLORIDE 406 373 4 9
OMEPRAZOLE 357 262 5 5
WARFARIN SODIUM 292 284 6 10
METFORMIN HCL 262 190 7 8
AMLODIPINE BESYLATE 260 249 8 7
LISINOPRIL 243 192 9 3
HYDROCODONE-ACETAMINOPHEN 240 143 S3 10 4
CITALOPRAM HBR 225 188 11 14
METOPROLOL SUCCINATE 214 195 12 17
ATENOLOL 200 171 13 16
PRAVASTATIN SODIUM 185 136 14 22
HYDROCHLOROTHIAZIDE 178 140 15 11
GABAPENTIN 171 113 16 12
NAMENDA 171 171 16 31
LOSARTAN POTASSIUM 165 113 18 19
RANITIDINE HCL 151 144 19 45
FAMOTIDINE 145 123 20 61
ESCITALOPRAM OXALATE 130 94 21 68
GLIMEPIRIDE 125 101 22 41
ALENDRONATE SODIUM 114 101 23 24
DIOVAN 111 92 24 63
TRAMADOL HCL 111 96 24 18
ATORVASTATIN CALCIUM 99 78 26 15
SPIRIVA 92 59 27 73
ENALAPRIL MALEATE 92 87 27 55
PANTOPRAZOLE SODIUM 89 78 29 37
DONEPEZIL HCL 88 88 30 26
ADVAIR DISKUS 86 63 31 60
DIOVAN HCT 84 84 32 145
ZETIA 82 55 33 81
LANTUS 81 73 34 39
CYCLOBENZAPRINE HCL 77 22 R 35 42
POLYETHYLENE GLYCOL 3350 76 69 36 36
DIGOXIN 74 73 37 32
DIVALPROEX SODIUM 70 70 38 86
DILTIAZEM 24HR CD 69 57 39 104
METOPROLOL TARTRATE 69 62 39 13
BYSTOLIC 66 52 41 110
CARVEDILOL 65 61 42 27
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 51 43 76
ISOSORBIDE MONONITRATE ER 63 51 44 85
NEXIUM 63 49 44 30
PREDNISONE 60 56 46 33
KLOR-CON M20 60 53 46 64
FENTANYL 59 48 S2 48 53
CEFUROXIME 58 52 49 182
CARBIDOPA-LEVODOPA 57 57 50 71
CLONIDINE HCL 55 48 51 67
CLOPIDOGREL 55 50 51 44
SERTRALINE HCL 50 37 53 21
MELOXICAM 50 47 53 23
AMOXICILLIN 50 39 53 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.